| BSE: 500674 | Sector: Health care |
| NSE: SANOFI | ISIN Code: INE058A01010 |
| BSE 00:00 | 18 Oct | 6100.40 |
45.10 (0.74%) |
OPEN
6120.00 |
HIGH
6275.00 |
LOW
5925.00 |
| NSE 00:00 | 18 Oct | 5996.25 |
-56.55 (-0.93%) |
OPEN
6300.00 |
HIGH
6300.00 |
LOW
5920.15 |
| OPEN | 6120.00 |
| PREVIOUS CLOSE | 6055.30 |
| VOLUME | 10121 |
| 52-Week high | 6584.00 |
| 52-Week low | 5300.00 |
| P/E | 36.14 |
| Mkt Cap.(Rs cr) | 14,049 |
| Buy Price | 5939.00 |
| Buy Qty | 2.00 |
| Sell Price | 5988.00 |
| Sell Qty | 2.00 |
Sanofi India Limited previously known as Aventis Pharma Limited is amongst the leading multinational companies in the Indian Pharmaceutical Market. It offers a wide array of medicines for therapy areas such as Diabetes Cardiology Thrombosis Central Nervous System and Antihistamines. The products manufactured by the company are distributed in India and exported to many developed as well as developi...> More
| COMPANY INFORMATION | |||||||
| Director : | Shailesh Ayyangar | ||||||
| Independent Director : | Rangaswamy R Iyer | ||||||
| Managing Director : | N Rajaram | ||||||
| Chairman & Independent Directo : | Aditya Narayan | ||||||
| Independent Director : | Usha Thorat | ||||||
| Company Secretary : | Girish Tekchandani | ||||||
| Director : | Cyril Grandchamp-Desraux | ||||||
| Director : | Thomas Rouckout | ||||||
| Whole Time Director & CFO : | Charles Billard | ||||||
| Whole-time Director : | Cherian Mathew | ||||||
| AUDITOR : | Price Waterhouse & Co Chartered Accountants LLP | ||||||
| IND NAME : | Pharmaceuticals - Multinational | ||||||
| HOUSE NAME : | MNC Associate - Hoechst | ||||||
| Registered office | |||||||
| Sanofi Hse 117-B Saki Vihar Rd, L&T Business Park Powai,Mumbai,Maharashtra-400072 | |||||||
| Ph : 91-22-28032000 | |||||||
| WEBSITE : http://www.sanofindialtd.com | |||||||
| E-mail : igrc.sil@sanofi.com | |||||||
